Terminology Service < Semantic Lookup Platform

All individuals in ONE

Label	Id	Description
Stage 1A (FIGO)	OBI_0002343	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T1a, N0, and M0.]
Stage 1B (FIGO)	OBI_0002344	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T1b, N0, and M0.]
Stage 1C (FIGO)	OBI_0002345	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T1c, N0, and M0.]
Stage 2 (FIGO)	OBI_0002346	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2, N0, and M0.]
Stage 2A (FIGO)	OBI_0002347	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2a, N0, and M0.]
Stage 2B (FIGO)	OBI_0002348	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2b, N0, and M0.]
Stage 2C (FIGO)	OBI_0002349	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T2c, N0, and M0.]
Stage 3 (FIGO)	OBI_0002350	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of (T3, N0, and M0) or (T3,3a,3b, NX, and M0).]
Stage 3A (FIGO)	OBI_0002351	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T3a, N0, and M0 .]
Stage 3B (FIGO)	OBI_0002352	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of T3b, N0, and M0 .]
Stage 3C (FIGO)	OBI_0002353	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of (T3c, N0,X and M0) or (any T, N1 and M0).]
Stage 4 (FIGO)	OBI_0002354	[A International Federation of Gynecology and Obstetrics ovarian cancer stage value specification associated with TNM stage values of any T, any N, and M1.]
Stage I (AJCC 7th)	OBI_0002317	[A clinical tumor stage group according to AJCC 7th edition indicating cancers that are smaller or less deeply invasive without regional disease or nodes.]
Stage IA (FIGO)	OBI_0002327	[An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating invasive carcinoma which can be diagnosed only by microscopy, with deepest invasion <5 mm and the largest extension <7 mm.]
Stage IA1 (FIGO)	OBI_0002328	[An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating measured stromal invasion of <3.0 mm in depth and extension of <7.0 mm.]
Stage IA2 (FIGO)	OBI_0002329	[An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating measured stromal invasion of >3.0 mm and not >5.0 mm with an extension of not >7.0 mm.]
Stage IB (FIGO)	OBI_0002330	[An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating clinically visible lesions limited to the cervix uteri or pre-clinical cancers greater than stage IA]
Stage IB1 (FIGO)	OBI_0002331	[An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating clinically visible lesion limited to the cervix uteri or pre-clinical cancers greater than stage IA <4.0 cm in greatest dimension.]
Stage IB2 (FIGO)	OBI_0002332	[An International Federation of Gynecology and Obstetrics cervical cancer stage value specification indicating clinically visible lesion limited to the cervix uteri or pre-clinical cancers greater than stage IA >4.0 cm in greatest dimension.]
Stage IIA (AJCC 7th)	OBI_0002318	[A clinical tumor stage group according to AJCC 7th edition indicating cancers with increasing tumor or nodal extent but less than in Stage III and with differing characteristics from IIB and IIC.]